Eurizon Capital SGR S.p.A. Makes New $26.99 Million Investment in Cigna Group $CI

Eurizon Capital SGR S.p.A. bought a new position in shares of Cigna Group (NYSE:CI) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 98,063 shares of the health services provider’s stock, valued at approximately $26,993,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Beacon Financial Strategies CORP bought a new position in Cigna Group during the 4th quarter worth about $28,000. Lodestone Wealth Management LLC bought a new position in Cigna Group during the 4th quarter worth about $32,000. Collier Financial bought a new position in Cigna Group during the 3rd quarter worth about $34,000. Creative Financial Designs Inc. ADV grew its holdings in Cigna Group by 147.3% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock worth $37,000 after acquiring an additional 81 shares in the last quarter. Finally, Activest Wealth Management grew its holdings in Cigna Group by 1,050.0% during the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock worth $38,000 after acquiring an additional 126 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 205,904 shares of company stock valued at $60,277,068 in the last three months. 0.60% of the stock is owned by insiders.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $277.08 on Friday. The firm has a market capitalization of $73.30 billion, a P/E ratio of 11.75, a PEG ratio of 1.00 and a beta of 0.30. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a 50 day moving average price of $278.32 and a 200 day moving average price of $276.88. Cigna Group has a 52 week low of $239.51 and a 52 week high of $338.89.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. Cigna Group’s revenue was up 4.6% on a year-over-year basis. During the same period last year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts expect that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CI. Piper Sandler lowered their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Guggenheim raised their price target on shares of Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. The Goldman Sachs Group raised their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Jefferies Financial Group lowered their price target on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. Finally, Cantor Fitzgerald raised their price target on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $339.50.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.